LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Delayed Early Genes Prevent Runaway Cell Division

By Biotechdaily staff writers
Posted on 05 Mar 2007
Cancer researchers have identified a cluster of genes in normal cells that prevent the type of runaway cell division that characterizes cancer cells.
When normal cells respond to the correct outside stimulus, such as binding of epidermal growth factor, to divide, a group of genes termed "immediate early genes” begin to function. Immediate early genes (IEGs) are activated transiently and rapidly in response to a wide variety of cellular stimuli. They represent a standing response mechanism that is activated at the transcription level in the first round of response to stimuli, before any new proteins are synthesized. Thus, IEGs are distinct from "late response” genes, which can only be activated later following the synthesis of early response gene products.
In the current study, investigators at the Weizmann Institute of Science (Rehovot, Israel) identified a distinct subset of IEGs that they call "delayed” early genes. The task of these genes is to suppress IEG activity so that cell division stops and does not spin out of control.
Their study, published in the February 25, 2007, online edition of Nature Genetics, revealed that after being triggered by the proper stimulus, a first wave of IEGs initiated cell division and was active for from 20 to 40 minutes. After that, four more waves of genetic activity, ranging from 40 to 240 minutes after the signal, were comprised primarily of gene activity tied to the process of halting cell division. Overall, the investigators identified 50 genes that interfered with the activities of the first wave of genes. This inhibitory system functioned by producing proteins that directly attached to the cell-division genes, hindering their activity.

As might be anticipated, analysis of the activity of the delayed early genes in cancerous tissues showed that they did not function or functioned only poorly. This misbehavior was directly linked to the aggressiveness of the cancer and the likelihood of the patient to recover.


Related Links:
Weizmann Institute of Science
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Sample Transportation System
Tempus1800 Necto

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more